Cue Biopharma Reports Third Quarter 2022 Financial Results

Go back to Cue Biopharma Reports Third Quarter 2022 Financial Results
(NASDAQ: CUE) Delayed: 24.61 -1.67 (6.35%)
Previous Close $26.28    52 Week High
Open $26.44    52 Week Low
Day High $28.11    P/E N/A 
Day Low $24.40    EPS
Volume 157,875